COLLEGIUM PHARMACEUTICAL, INC. Series B Convertible Preferred Stock Purchase Agreement Dated as of February10, 2012Series B Convertible Preferred Stock Purchase Agreement • April 2nd, 2015 • Collegium Pharmaceutical, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledApril 2nd, 2015 Company Industry JurisdictionThis Series B Convertible Preferred Stock Purchase Agreement (“Agreement”) dated as of February 10, 2012 is entered into by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the “Company”), and the individuals and entities listed on Schedule A hereto (each a “Purchaser” and collectively, the “Purchasers”). In consideration of the mutual promises and covenants contained in this Agreement, the parties hereto agree as follows:
COLLEGIUM PHARMACEUTICAL, INC. Series B Convertible Preferred Stock Purchase Agreement Dated as of February10, 2012Series B Convertible Preferred Stock Purchase Agreement • March 3rd, 2015 • Collegium Pharmaceutical Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 3rd, 2015 Company Industry JurisdictionThis Series B Convertible Preferred Stock Purchase Agreement (“Agreement”) dated as of February 10, 2012 is entered into by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the “Company”), and the individuals and entities listed on Schedule A hereto (each a “Purchaser” and collectively, the “Purchasers”). In consideration of the mutual promises and covenants contained in this Agreement, the parties hereto agree as follows: